Trial · NCT03197662
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Efficacy of Peptide Intranasal Oxytocin (IN-OXT) | Experimental: Intranasal Oxytocin (IN-OXT) | -6.08 | Standard Deviation 5.65 | score on a scale | |
| Change in Efficacy of Peptide Intranasal Oxytocin (IN-OXT) | Placebo Comparator: Matched Placebo | -6.64 | Standard Deviation 5.05 | score on a scale | |
| Change in Repetitive Behavior | Experimental: Intranasal Oxytocin (IN-OXT) | -13.2 | Standard Deviation 14.4 | score on a scale | |
| Change in Repetitive Behavior | Placebo Comparator: Matched Placebo | -8.53 | Standard Deviation 8.89 | score on a scale | |
| Change in Rigid Behavior | Experimental: Intranasal Oxytocin (IN-OXT) | -8.43 | Standard Deviation 5.15 | score on a scale | |
| Change in Rigid Behavior | Placebo Comparator: Matched Placebo | -11.2 | Standard Deviation 7.86 | score on a scale | |
| Change in Body Weight | Experimental: Intranasal Oxytocin (IN-OXT) | 0.585 | Standard Deviation 0.709 | kilograms | |
| Change in Body Weight | Placebo Comparator: Matched Placebo | -0.0669 | Standard Deviation 2.14 | kilograms | |
| Body Composition | Experimental: Intranasal Oxytocin (IN-OXT) | 23.5 | Full Range 15.0 to 53.7 | percentage of fat | |
| Body Composition | Placebo Comparator: Matched Placebo | 24.3 | Full Range 18.2 to 43.4 | percentage of fat | |
| Change in Body Mass Index (BMI) | Experimental: Intranasal Oxytocin (IN-OXT) | 0.229 | Standard Deviation 1.26 | kg/m2 | |
| Change in Body Mass Index (BMI) | Placebo Comparator: Matched Placebo | -0.357 | Standard Deviation 0.911 | kg/m2 | |
| Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire: Domain 1 (Physical Health) | Experimental: Intranasal Oxytocin (IN-OXT) | -0.0714 | Standard Deviation 2.89 | score on a scale | |
| Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire: Domain 1 (Physical Health) | Placebo Comparator: Matched Placebo | -0.929 | Standard Deviation 3.47 | score on a scale | |
| Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire - Domain 2 (Psychological Health) | Experimental: Intranasal Oxytocin (IN-OXT) | -0.500 | Standard Deviation 1.99 | score on a scale | |
| Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire - Domain 2 (Psychological Health) | Placebo Comparator: Matched Placebo | -1.86 | Standard Deviation 3.90 | score on a scale | |
| Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire - Domain 3 (Social Relationships) | Experimental: Intranasal Oxytocin (IN-OXT) | 0.00 | Standard Deviation 1.80 | score on a scale | |
| Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire - Domain 3 (Social Relationships) | Placebo Comparator: Matched Placebo | 0.0714 | Standard Deviation 2.43 | score on a scale | |
| Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire - Domain 4 (Environment) | Experimental: Intranasal Oxytocin (IN-OXT) | -0.0714 | Standard Deviation 1.86 | score on a scale | |
| Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire - Domain 4 (Environment) | Placebo Comparator: Matched Placebo | 0.571 | Standard Deviation 4.50 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03197662/results